AC Immune SA Appoints New Chief Medical Officer
26 juil. 2023 07h00 HE
|
AC Immune SA
AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee member Lausanne, Switzerland, July 26, 2023 – AC Immune SA (NASDAQ:...
AC Immune Showcasing Precision Medicine Programs at AAIC 2023
03 juil. 2023 07h00 HE
|
AC Immune SA
AC Immune Showcasing Precision Medicine Programs at AAIC 2023 Lausanne, Switzerland, July 3, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision...
Silo Pharma Commences Study of Novel Joint Homing Peptide SPU-21
30 mai 2023 09h00 HE
|
Silo Pharma, Inc.
Phase 2 of study will further investigate the peptides’ method, optimization, and binding affinity in human tissue ENGLEWOOD CLIFFS, NJ, May 30, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq:...
Alzheimer’s Disease Diagnostic Market Size Worth USD 7100 Million by 2030 at 8.90% CAGR – Report by Market Research Future (MRFR)
24 mai 2023 14h00 HE
|
Market Research Future
New York, May 24, 2023 (GLOBE NEWSWIRE) -- Alzheimer’s Disease Diagnostic Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Alzheimer’s Disease...
Pan-Biome Pharmaceuticals, a startup focused on age-related diseases and increasing human healthspan, reports positive results in a preclinical trial of colitis
25 avr. 2023 10h00 HE
|
Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on age-related diseases and extending...
Silo Pharma to Present at Psychedelic Drug Development Conference
24 avr. 2023 08h15 HE
|
Silo Pharma, Inc.
ENGLEWOOD CLIFFS, NJ, April 24, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional...
IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022
14 févr. 2023 19h41 HE
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Feb. 14, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (dba IGC, Inc.) (NYSE American: IGC) (“IGC” or the “Company”) today reported its third fiscal...
IGC to be Featured in Feb. 10 Radius Research Investor Webinar
08 févr. 2023 08h30 HE
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Feb. 08, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces that Ram Mukunda, CEO, and Claudia...
IGC Receives No Objection Letter from Health Canada
04 janv. 2023 08h00 HE
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”) today announces it has received a no objection...
IGC Announces Updated Life Sciences Presentation
20 déc. 2022 08h30 HE
|
INDIA GLOBALIZATION CAPITAL INC.
POTOMAC, Md., Dec. 20, 2022 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American: IGC) (“IGC” or the “Company”), today announces that a life sciences presentation has been filed with...